Skip to main content
Erschienen in: Strahlentherapie und Onkologie 9/2017

15.06.2017 | Original Article

Impact of a rectal and bladder preparation protocol on prostate cancer outcome in patients treated with external beam radiotherapy

verfasst von: Dr. A. Maggio, Dr. D. Gabriele, Dr. E. Garibaldi, Dr. S. Bresciani, Dr. E. Delmastro, Dr. A. Di Dia, Dr. A. Miranti, Dr. M. Poli, Dr. T. Varetto, Dr. M. Stasi, Dr. P. Gabriele

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose and objective

To test the hypothesis that a rectal and bladder preparation protocol is associated with an increase in prostate cancer specific survival (PCSS), clinical disease free survival (CDFS) and biochemical disease free survival (BDFS).

Patients and methods

From 1999 to 2012, 1080 prostate cancer (PCa) patients were treated with three-dimensional conformal radiotherapy (3DCRT). Of these patients, 761 were treated with an empty rectum and comfortably full bladder (RBP) preparation protocol, while for 319 patients no rectal/bladder preparation (NRBP) protocol was adopted.

Results

Compared with NRBP patients, patients with RBP had significantly higher BDFS (64% vs 48% at 10 years, respectively), CDFS (81% vs 70.5% at 10 years, respectively) and PCSS (95% vs 88% at 10 years, respectively) (log-rank test p < 0.001). Multivariate analysis (MVA) indicated for all treated patients and intermediate high-risk patients that the Gleason score (GS) and the rectal and bladder preparation were the most important prognostic factors for PCSS, CDFS and BDFS. With regard to high- and very high-risk patients, GS, RBP, prostate cancer staging and RT dose were predictors of PCSS, CDFS and BDFS in univariate analysis (UVA).

Conclusion

We found strong evidence that rectal and bladder preparation significantly decreases biochemical and clinical failures and the probability of death from PCa in patients treated without daily image-guided prostate localization, presumably since patients with RBP are able to maintain a reproducibly empty rectum and comfortably full bladder across the whole treatment compared with NRPB patients.
Literatur
1.
Zurück zum Zitat Zelefsky MJ, Leibel SA, Gaudin PB et al (1998) Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41:491–500CrossRefPubMed Zelefsky MJ, Leibel SA, Gaudin PB et al (1998) Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41:491–500CrossRefPubMed
2.
Zurück zum Zitat Antolak JA, Rosen II, Childress CH et al (1998) Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 42:661–672CrossRefPubMed Antolak JA, Rosen II, Childress CH et al (1998) Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 42:661–672CrossRefPubMed
3.
Zurück zum Zitat Zelefsky MJ, Crean D, Mageras GS et al (1999) Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 50:225–234CrossRefPubMed Zelefsky MJ, Crean D, Mageras GS et al (1999) Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 50:225–234CrossRefPubMed
4.
Zurück zum Zitat Van Herk M, Bruce A, Kroes AP et al (1995) Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 33:1311–1320CrossRefPubMed Van Herk M, Bruce A, Kroes AP et al (1995) Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 33:1311–1320CrossRefPubMed
5.
Zurück zum Zitat Balter JM, Sandler HM, Lam K et al (1995) Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys 31:113–118CrossRefPubMed Balter JM, Sandler HM, Lam K et al (1995) Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys 31:113–118CrossRefPubMed
6.
Zurück zum Zitat Stroom JC, Koper PC, Korevaar GA et al (1999) Internal organ motion in prostate cancer patients treated in prone and supine treatment position. Radiother Oncol 51:237–248CrossRefPubMed Stroom JC, Koper PC, Korevaar GA et al (1999) Internal organ motion in prostate cancer patients treated in prone and supine treatment position. Radiother Oncol 51:237–248CrossRefPubMed
7.
Zurück zum Zitat Rudat V, Schraube P, Oetzel D et al (1996) Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 35:1027–1034CrossRefPubMed Rudat V, Schraube P, Oetzel D et al (1996) Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 35:1027–1034CrossRefPubMed
8.
Zurück zum Zitat Nguyen T, Boldt RG, Rodrigues G (2015) Prognostic factors for prostate cancer endpoints following biochemical failure: a review of the literature. Cureus 7(1):e238PubMedPubMedCentral Nguyen T, Boldt RG, Rodrigues G (2015) Prognostic factors for prostate cancer endpoints following biochemical failure: a review of the literature. Cureus 7(1):e238PubMedPubMedCentral
9.
Zurück zum Zitat Zelefsky MJ, Pei X, Chou JF, Schechter M, Kollmeier M, Cox B, Yamada Y, Fidaleo A, Sperling D, Happersett L, Zhang Z (2011) Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes. Eur Urol 60(6):1133–1139CrossRefPubMed Zelefsky MJ, Pei X, Chou JF, Schechter M, Kollmeier M, Cox B, Yamada Y, Fidaleo A, Sperling D, Happersett L, Zhang Z (2011) Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes. Eur Urol 60(6):1133–1139CrossRefPubMed
10.
Zurück zum Zitat Zelefsky MJ, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O, Park J, Shippy A (2008) Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 71(4):1028–1033CrossRefPubMed Zelefsky MJ, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O, Park J, Shippy A (2008) Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 71(4):1028–1033CrossRefPubMed
11.
Zurück zum Zitat Heemsberg W, Hoogeman M, Witte M et al (2007) Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 Gy versus 78 Gy. Int J Radiat Oncol Biol Phys 67(5):1418–1424CrossRef Heemsberg W, Hoogeman M, Witte M et al (2007) Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 Gy versus 78 Gy. Int J Radiat Oncol Biol Phys 67(5):1418–1424CrossRef
12.
Zurück zum Zitat de Crevoisier R, Tucker S, Dong L et al (2005) Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62(4):965–973CrossRefPubMed de Crevoisier R, Tucker S, Dong L et al (2005) Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62(4):965–973CrossRefPubMed
13.
Zurück zum Zitat D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick G, Tomaszewski J, Renshaw A, Kaplan I, Beard C, Wein A (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974CrossRefPubMed D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick G, Tomaszewski J, Renshaw A, Kaplan I, Beard C, Wein A (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974CrossRefPubMed
14.
Zurück zum Zitat Antolak JA, Rosen II, Childress CH et al (1998) Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 42:661–672CrossRefPubMed Antolak JA, Rosen II, Childress CH et al (1998) Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 42:661–672CrossRefPubMed
15.
Zurück zum Zitat Chen ME, Johnston DA, Tang K et al (2000) Detailed mapping of prostate carcinoma foci: Biopsy strategy implications. Cancer 89:1800–1809CrossRefPubMed Chen ME, Johnston DA, Tang K et al (2000) Detailed mapping of prostate carcinoma foci: Biopsy strategy implications. Cancer 89:1800–1809CrossRefPubMed
16.
Zurück zum Zitat Greene DR, Wheeler TM, Egawa S et al (1991) Relationship between clinical stage and histological zone of origin in early prostate cancer: Morphometric analysis. Br J Urol 68:499–509CrossRefPubMed Greene DR, Wheeler TM, Egawa S et al (1991) Relationship between clinical stage and histological zone of origin in early prostate cancer: Morphometric analysis. Br J Urol 68:499–509CrossRefPubMed
17.
Zurück zum Zitat Schultheiss TE, Lee WR, Hunt MA et al (1997) Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37:3–11CrossRefPubMed Schultheiss TE, Lee WR, Hunt MA et al (1997) Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37:3–11CrossRefPubMed
18.
Zurück zum Zitat Jackson A, Skwarchuk MW, Zelefsky MJ (2001) Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49:685–698CrossRefPubMed Jackson A, Skwarchuk MW, Zelefsky MJ (2001) Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49:685–698CrossRefPubMed
19.
Zurück zum Zitat Lee WR, Hanks GE, Hanlon AL et al (1996) Lateral rectal shielding reduces late rectal morbidity following high-dose three dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect. Int J Radiat Oncol Biol Phys 35:251–257CrossRefPubMed Lee WR, Hanks GE, Hanlon AL et al (1996) Lateral rectal shielding reduces late rectal morbidity following high-dose three dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect. Int J Radiat Oncol Biol Phys 35:251–257CrossRefPubMed
20.
Zurück zum Zitat O’Doherty UM, McNair HA, Norman AR et al (2006) Variability of bladder filling in patients receiving radical radiotherapy to the prostate. Radiother Oncol 79(3):335–340CrossRefPubMed O’Doherty UM, McNair HA, Norman AR et al (2006) Variability of bladder filling in patients receiving radical radiotherapy to the prostate. Radiother Oncol 79(3):335–340CrossRefPubMed
21.
Zurück zum Zitat Stasi M, Munoz F, Fiorino C et al (2006) Emptying the rectum before treatment delivery limits the variations of rectal dose – volume parameters during 3DCRT of prostate cancer. Radiother Oncol 80(3):363–370CrossRefPubMed Stasi M, Munoz F, Fiorino C et al (2006) Emptying the rectum before treatment delivery limits the variations of rectal dose – volume parameters during 3DCRT of prostate cancer. Radiother Oncol 80(3):363–370CrossRefPubMed
22.
Zurück zum Zitat Gleason DF (1977) The veterans administrative cooperative urologic research group. Histological grading and clinical staging of prostatic carcinoma. Urologic Pathology: The prostate. Lea and Febiger, Philadelphia, pp 171–198 Gleason DF (1977) The veterans administrative cooperative urologic research group. Histological grading and clinical staging of prostatic carcinoma. Urologic Pathology: The prostate. Lea and Febiger, Philadelphia, pp 171–198
23.
Zurück zum Zitat Sogani PC, Israel A, Lieberman PH, Lesser ML, Whitmore WF (1985) Gleason grading of prostate cancer: a predictor of survival. Urology 25:223–227CrossRefPubMed Sogani PC, Israel A, Lieberman PH, Lesser ML, Whitmore WF (1985) Gleason grading of prostate cancer: a predictor of survival. Urology 25:223–227CrossRefPubMed
24.
Zurück zum Zitat Björk T, Lilja H, Christensson A (1999) The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer. BJU Int 84(9):1021–1027CrossRefPubMed Björk T, Lilja H, Christensson A (1999) The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer. BJU Int 84(9):1021–1027CrossRefPubMed
27.
Zurück zum Zitat Park SS, Yan D, McGrath S et al (2012) Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence. Int J Radiat Oncol Biol Phys 83(3):947–952CrossRefPubMed Park SS, Yan D, McGrath S et al (2012) Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence. Int J Radiat Oncol Biol Phys 83(3):947–952CrossRefPubMed
28.
Zurück zum Zitat Kupelian PA, Willoughby TR, Reddy CA et al (2008) Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70(4):1146–1150CrossRefPubMed Kupelian PA, Willoughby TR, Reddy CA et al (2008) Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70(4):1146–1150CrossRefPubMed
29.
Zurück zum Zitat Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A (2010) AJCC cancer staging manual, 7th edn. Springer, New York NY Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A (2010) AJCC cancer staging manual, 7th edn. Springer, New York NY
30.
Zurück zum Zitat Albertsen PC, Hanley JA, Barrows GH et al (2005) Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97(17):1248–1253CrossRefPubMed Albertsen PC, Hanley JA, Barrows GH et al (2005) Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97(17):1248–1253CrossRefPubMed
31.
Zurück zum Zitat Gofrit ON, Zorn KC, Steinberg GD, Zagaja GP, Shalhav AL (2008) The Will Rogers phenomenon in urological oncology. J Urol 179:28–33CrossRefPubMed Gofrit ON, Zorn KC, Steinberg GD, Zagaja GP, Shalhav AL (2008) The Will Rogers phenomenon in urological oncology. J Urol 179:28–33CrossRefPubMed
32.
Zurück zum Zitat Zelefsky MJ, Fuks Z, Hunt M et al (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53(5):1111–1116CrossRefPubMed Zelefsky MJ, Fuks Z, Hunt M et al (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53(5):1111–1116CrossRefPubMed
33.
Zurück zum Zitat Zelefsky MJ, Fuks Z, Happersett L et al (2000) Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55:241–249CrossRefPubMed Zelefsky MJ, Fuks Z, Happersett L et al (2000) Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55:241–249CrossRefPubMed
34.
Zurück zum Zitat Michalski JM, Yan Y, Watkins-Bruner D et al (2013) Preliminary toxicity analysis of 3‑dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys 87:932–938CrossRefPubMed Michalski JM, Yan Y, Watkins-Bruner D et al (2013) Preliminary toxicity analysis of 3‑dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys 87:932–938CrossRefPubMed
35.
Zurück zum Zitat Sheets NC, Goldin GH, Meyer AM et al (2012) Intensity-modulated radiation therapy, proton therapy, or Conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 307(15):1611–1620CrossRefPubMedPubMedCentral Sheets NC, Goldin GH, Meyer AM et al (2012) Intensity-modulated radiation therapy, proton therapy, or Conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 307(15):1611–1620CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Arnaud A, Maingon P, Gauthier M et al (2014) Image-guided IMRT for localized prostate cancer with daily repositioning: Inferring the difference between planned dose and delivered dose distribution. Phys Med 30:669–675CrossRefPubMed Arnaud A, Maingon P, Gauthier M et al (2014) Image-guided IMRT for localized prostate cancer with daily repositioning: Inferring the difference between planned dose and delivered dose distribution. Phys Med 30:669–675CrossRefPubMed
37.
Zurück zum Zitat Pollack A, Zagars GK, Smith LG et al (2000) Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18(23):3904–3911CrossRefPubMed Pollack A, Zagars GK, Smith LG et al (2000) Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18(23):3904–3911CrossRefPubMed
Metadaten
Titel
Impact of a rectal and bladder preparation protocol on prostate cancer outcome in patients treated with external beam radiotherapy
verfasst von
Dr. A. Maggio
Dr. D. Gabriele
Dr. E. Garibaldi
Dr. S. Bresciani
Dr. E. Delmastro
Dr. A. Di Dia
Dr. A. Miranti
Dr. M. Poli
Dr. T. Varetto
Dr. M. Stasi
Dr. P. Gabriele
Publikationsdatum
15.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 9/2017
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-017-1163-4

Weitere Artikel der Ausgabe 9/2017

Strahlentherapie und Onkologie 9/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.